Activists at AIDS2024 demand: Break Gilead’s Lenacapavir monopoly
July 23, 2024Gilead’s Price is 1,000 Times the Target Generic Price for 100% Effective Prevention ShotMunich, 23 July 2024: Today at the International AIDS Conference, a coalition of activists, including Médecins Sans Frontières (MSF), called for immediate global action to break Gilead’s...
Read more
MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB drug
July 17, 2024Mumbai, 17 July 2024 – On Friday 5 July 2024, the “pre-grant opposition” filed in December 2020 by The Delhi Network of Positive People (DNP+) and a Mumbai-based tuberculosis (TB) survivor Ganesh Acharya, and supported by Médecins Sans Frontières/Doctors Without...
Read more
MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa
July 8, 2024The patent withdrawal is a result of an unprecedented investigation by South Africa’s Competition Commission into J&J We welcome today’s news that following the Competition Commission’s investigation initiation into anti-competitive practice, J&J has officially withdrawn its secondary patents in South...
Read more
Secrets Cost Lives: Transparency and access to medical products
July 5, 2024As an international medical humanitarian organisation, Médecins Sans Frontières/Doctors Without Borders (MSF) has repeatedly witnessed how the world’s most vulnerable people are left without access to the lifesaving medicines, diagnostics tests and vaccines they need. Ensuring access to these medical...
Read more
Danaher continues to charge exorbitant prices for lifesaving medical tests despite urgent demands for price reductions by several Ministries of Health
June 18, 2024Geneva, 17 June 2024 - In September 2023, the US corporation Danaher, which owns diagnostics maker Cepheid, announced a price reduction of the primary GeneXpert test used to diagnose tuberculosis (TB), from US$9.98 to $7.97, amid pressure from TB activists....
Read more
Urgent call for Europe to improve treatment access for tuberculosis: Many TB medicines and formulations accessible in lower- and middle-income countries remain unaffordable or unavailable in Europe
June 7, 2024Berlin, 6 June 2024: As the World Health Organization (WHO) concluded a meeting with European health officials and civil society to improve access to tuberculosis (TB) medicines in the European Union (EU)/European Economic Area (EEA), Médecins Sans Frontières/Doctors Without Borders...
Read more
Gavi’s next strategy must make sure to reach the 10 million children in fragile and humanitarian settings who are missing vaccines
June 4, 2024Where are we now? This week, on 6-7 June 2024, the Board of Gavi, the Vaccine Alliance, is meeting in Geneva to approve and endorse the one-page framework for Gavi 6.0, which outlines its strategy for the five-year period from...
Read more
MSF reveals cost of its landmark TB clinical trial: €34 million
April 26, 2024MSF urges public and non-profit actors to publish clinical trial costs to improve access to medical products for all. Geneva, 25 April 2024 - At the 5th WHO Pharmaceutical Pricing and Reimbursement Policies conference today, Doctors Without Borders/Médecins Sans Frontières...
Read more
As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination
April 16, 2024With routine vaccination efforts failing to reach people in fragile and emergency settings, MSF is seeing low vaccination coverage and more outbreaks of vaccine-preventable diseases, like diphtheria and measles Geneva, 15 April 2024 – Ahead of Gavi, the Vaccine Alliance’s Board...
Read more
Time for $5: MSF demands Cepheid and Danaher lower the price of medical tests
March 22, 2024Help us stop the profiteering on medical tests Sign the petition to demand drug manufacturers Cepheid and Danaher drop the price of GeneXpert tests for low- and middle-income countries. MSF and partners protest outside Danaher in Washington, DC, demanding price...
Read more
MSF response to signing of EFTA-India trade agreement
March 12, 2024Geneva/Delhi, 12 March 2024: On 10 March 2024, it was announced that India and the European Free Trade Association (EFTA) signed a free trade agreement (FTA) they have been negotiating since 2006. Full text of agreement along with Annex and the Record...
Read more
MSF warns governments are failing to test, treat and prevent TB in children
November 14, 2023Governments must immediately implement the latest WHO guidelines to stop children from dying from this deadly yet curable disease Geneva, 14 November 2023 - Médecins Sans Frontières/Doctors Without Borders (MSF) welcomed the World Health Organization’s (WHO) ‘Roadmap towards ending TB in...
Read more
